Sabby Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,489
Closed -$39.9M 171
2021
Q4
$39.9M Buy
+5,489
New +$378K 5.79% 4
2020
Q2
Sell
-2,166
Closed -$2.76M 110
2020
Q1
$2.76M Buy
+2,166
New +$150K 1.15% 11
2018
Q1
Sell
-454
Closed -$3.25M 166
2017
Q4
$3.25M Hold
454
0.3% 43
2017
Q3
$3.68M Hold
454
0.24% 46
2017
Q2
$3.21M Sell
454
-7,832
-95% -$521K 0.21% 57
2017
Q1
$56.3M Buy
8,286
+3,969
+92% +$279K 3.04% 9
2016
Q4
$30.9M Sell
4,317
-7,374
-63% -$548K 1.8% 15
2016
Q3
$92.5M Buy
+11,691
New +$950K 3.47% 6
2016
Q2
Sell
-8,440
Closed -$77.5M 308
2016
Q1
$77.5M Sell
8,440
-1,314
-13% -$118K 3.88% 7
2015
Q4
$98.7M Sell
9,754
-142
-1% -$14.8K 5.43% 5
2015
Q3
$97.2M Sell
9,896
-2,981
-23% -$331K 4% 4
2015
Q2
$151M Buy
12,877
+2,910
+29% +$318K 5.5% 5
2015
Q1
$97.8M Buy
9,967
+9,170
+1,151% +$931K 4.07% 5
2014
Q4
$7.51K Sell
797
-1,491
-65% -$154K 0.24% 55
2014
Q3
$24.4K Sell
2,288
-718
-24% -$70.3K 0.94% 20
2014
Q2
$16.6M Buy
3,006
+13
+0.4% +$1.01K 0.71% 26
2014
Q1
$21.2M Buy
2,993
+993
+50% +$77.9K 1.19% 21
2013
Q4
$15M Sell
2,000
-500
-20% -$34.8K 0.96% 25
2013
Q3
$15.7M Sell
2,500
-206
-8% -$12.3K 1.02% 27
2013
Q2
$13.9M Buy
+2,706
New +$141K 0.92% 28

Other funds holding GILD

Sabby Management's GILD Position: Q4 2015 in Review

Sabby Management sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 45,140 shares — an estimated $4.7M sold.

Sabby Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $11M in Q1 2014. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Sabby Management reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • Sabby Management sold 45,140 Gilead Sciences shares in Q4 2015, an estimated $4.7M.
  • Sabby Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
  • Sabby Management's Gilead Sciences position peaked at $11M in Q1 2014.
  • 1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Sabby Management's 13F filing for Q4 2015, filed 16 Feb 2016.